By Julia Musto
Pfizer and BioNTech SE said Wednesday that they had inked a $3.2 billion agreement with the U.S. government for 105 million doses of their COVID-19 vaccine.
The deal includes new versions of the shots, and they would be delivered by the fall, pending a decision by the Food and Drug Administration (FDA).
Federal officials say the deal includes the option to purchase a total of 300 million vaccine doses.
Click the link below to read the rest of this story
Click here to get more news from the Bulldog
On the go, but don’t want to miss any Bulldog news? Go to the App Store and downloads apps for Bulldog Reports and The Bulldog Show to your Apple and Android mobile devices. It’s free!